Abstract
When headache is made a medical complaint, the headache is almost always migraine. However, the clinician should not be lulled into a sense of complacency. The first question rightly remains “Is this a primary (headache as disease) or secondary (headache as symptom)?” Red flags are helpful in identifying which headaches require further investigations and validated brief questionnaires have been developed for diagnosing migraine. Once a diagnosis is made, the patient should be told what is causing their headache and in the case of migraine that their headache is not the result of a serious threat to their life. It is important for the patient to accept that migraine alone is a sufficient explanation for their headache.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53:427–36.
Friedman BW, Serrano D, Reed M, Diamond M, Lipton RB. Use of the emergency department for severe headache. A population-based study. Headache. 2009;49:21–30.
Thomas E, Boardman HF, Ogden H, Millson DS, Croft PR. Advice and care for headaches: Who seeks it, who gives it? Cephalalgia. 2004;24:740–52.
Evans RW, Evans RE. What causes migraine: which physician explanation do patients prefer and understand? Headache. 2009;49:1536–40.
Holroyd KA, Cordingley GE, Pingel JD, Jerome A, Theofanous AG, Jackson DK, Leard L. Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management. Headache. 1989;29:148–53.
Kelman L. Pain characteristics of the acute migraine attack. Headache. 2006;46:942–53.
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
Kelman L. Migraine pain location” a tertiary care study of 1283 migraineurs. Headache. 2005;45:1038–47.
Houle TT, Turner DP, Houle TA, Smitherman TA, Martin V, Penzien DB, et al. Rounding behavior in the reporting of headache frequency complicates headache chronification research. Headache. 2013;53:908–19.
Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic and chronic migraine. Curr Pain Headache Rep. 2012;16:86–92.
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157–68.
Marcus DA. Serotonin and its role in headache pathogenesis and treatment. Clin J Pain. 1993;9:159–67.
Marcus DA. Interrelationships of neurochemicals, estrogen, and recurring headache. Pain. 1995;62:129–39.
Vargas BB. Tension-type headache and migraine: two points on a continuum? Curr Pain Headache Rep. 2008;12:433–6.
[No authors listed]. Management of medication overuse headache. Drug Ther Bull 2010;48:2–6.
Diener H-C, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;3:475–83.
Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology. 2008;71:1821–8.
Diener H-C, Katasarva Z. Analgesic/abortive overuse and misuse in chronic daily headache. Curr Pain Headache Rep. 2001;5:545–50.
Mathew NT, Kurman R, Perez F. Drug-induced refractory headache–clinical features and management. Headache. 1990;30:634–8.
Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.
Tepper SJ, Dahlöf CH, Dowson A, Newman L, Mansbach H, Jones M, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark study. Headache. 2004;44:856–64.
Oliveria DV, Leite AA, Rocha-Filho PS. Which patients with headache do not seek medical attention? Headache. 2011;51:1279–84.
Goldstein JN, Camargo CA, Pelletier AJ, Edlow JA. Headache in the United States emergency departments: demographics, work-up and frequency of pathological disease. Cephalalgia. 2006;26:684–90.
Snyder H, Robinson K, Shah D, Brennan R, Handrigan M. Signs and symptoms of patients with brain tumors presenting to the emergency department. J Emerg Med. 1993;11:253–8.
Pfund Z, Szapáry L, Jászberényi O, Nagy F, Czopf J. Headache in intracranial tumors. Cephalalgia. 1999;19:787–90.
Chang SM, Parney IF, Huang W, Anderson Jr FA, Asher AL, Bernstein M, et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005;293:557–64.
Chandana SR, Movva S, Arora M, Singh T. Primary brain tumors in adults. Am Fam Physician. 2008;77:1423–30.
Valentinis L, Tuniz F, Valent F, Mucchiut M, Little D, Skrap M, et al. Headache attributed to intracranial tumours: a prospective cohort study. Cephalalgia. 2010;30:389–98.
Vázquez-Barquero A, Ibáñez FJ, Herrera S, Izquierdo JM, Berciano J, Pascual J. Isolated headache as the presenting clinical manifestation of intracranial tumors: a prospective study. Cephalalgia. 1994;14:270–2.
Schankin CJ, Ferrari U, Reinisch VM, Birnbaum T, Goldbrunner R, Straube A. Characteristics of brain tumour-associated headache. Caphalalgia. 2007;27:904–11.
Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43:1678–83.
Girdley FM, Rifkin AR. Headache secondary to mass responsive to sumatriptan: a brief report from primary care. Headache. 2012;52(10):1590–2.
Prokhorov S, Khanna S, Alapati D, Pallimalli SL. Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis. Headache. 2008;48:1235–6.
Rosenberg JH, Silberstein SD. The headache of SAH responds to sumatriptan. Headache. 2005;45:597–8.
Pfadenhauer K, Schönsteiner T, Keller H. The risks of sumatriptan administration in patients with unrecognized subarachnoid haemorrhage (SAH). Cephalalgia. 2006;26:320–3.
Sprigge JS. The use of sumatriptan in the treatment of postdural puncture headache after accidental lumbar puncture complicated a blood patch procedure. Anaesthesia. 1999;54:95–6.
Basurto Ona X, Martiínez García L, Solà I, Bonfill CX. Drug therapy for treating post-dural puncture headache. Cochrane Database Syst Rev. 2011;(10):CD007887
Lowry JK, Snyder JJ, Lowry PW. Brain tumors in the elderly. Recent trends in a Minnesota Cohort study. Arch Neurol. 1998;55:922–8.
Molineus A, Boxberger N, Redlick A, Vorwerk P. Brain tumors in children. Time to diagnosis – a single centre experience. Pediatr Int. 2013;55(3):305–9.
Klitbo DM, Nielsen R, Illum NO, Skov P, Carlsen N. Symptoms and time to diagnosis in children with brain tumours. Dan Med Bul. 2011;58:A4285.
Eross E, Dodick D, Eross M. The sinus, allergy Migraine Study. Headache. 2007;47(2):213–24.
Swidan SZ, Lake AE, Saper JR. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr Pain Headache Rep. 2005;9:65–70.
Patel ZM, Kennedy DW, Setzen M, Poetker DM, DelGaudio JM. “Sinus headache”: rhinogenic headache or migraine? An evidence-based guide to diagnosis and treatment. Int Forum Allergy Rhinol. 2013;3:221–30.
Obermann M, Yoon MS, Dommes P, Kuznetsova J, Maschke M, Weimar C, et al. Prevalence of trigeminal autonomic symptoms in migraine: a population-based study. Cephalalgia. 2007;27:504–9.
Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al. A self-administered screener for migraine in primary care: the ID Migraine™ validation study. Neurology. 2003;61:375–82.
Ertaş M, Baykan B, Tuncel D, Gökçe M, Gökçay F, Sirin H, et al. A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics. Cephalalgia. 2009;29:68–75.
Mostardini C, d’Agostino VC, Dugoni DE, Cerbo R. A possible role of ID-Migraine in the emergency department: study of an emergency department out-patient population. Cephalalgia. 2009;29:1326–30.
Siva A, Zrifoglu M, Ertaş M, Saip S, Karli HN, Baykan B, et al. Validity of the ID-Migraine screener in the workplace. Neurology. 2008;70:1337–45.
Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM. Does this patient with headache have a migraine or need neuroimaging? JAMA. 2006;296:1274–83.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this chapter
Cite this chapter
Marcus, D.A., Ready, D.M. (2017). Sorting Through Headache Patterns. In: Discussing Migraine With Your Patients. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6484-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6484-0_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-6482-6
Online ISBN: 978-1-4939-6484-0
eBook Packages: MedicineMedicine (R0)